Bevacizumab Recruiting Phase 2 Trials for Icotinib (DB11737)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0050831 (Bevacizumab) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05263947 | Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation | Treatment |